Detalhe da pesquisa
1.
Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection.
Gut
; 72(7): 1385-1398, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36697207
2.
The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysis.
J Viral Hepat
; 30(5): 448-454, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36740893
3.
JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection.
Gastroenterology
; 159(2): 521-533.e9, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32343960
4.
Sorted B cell transcriptomes point towards actively regulated B cell responses during ongoing chronic hepatitis B infections.
Cell Immunol
; 362: 104283, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33548734
5.
Identification and treatment of viral hepatitis C in persons who use drugs: a prospective, multicenter outreach study in Flanders, Belgium.
Harm Reduct J
; 18(1): 54, 2021 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34001145
6.
JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1.
Hepatology
; 69(6): 2349-2363, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30693573
7.
Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C virus genotype 1- and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observational studies from 13 countries.
J Viral Hepat
; 26(6): 685-696, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30739368
8.
Deferred treatment with a fixed-dose combination of sofosbuvir-velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infection.
J Viral Hepat
; 26(10): 1229-1232, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31216086
9.
Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis.
Liver Int
; 38(3): 443-450, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28756625
10.
Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbuvir-Ledipasvir Regimen.
Antimicrob Agents Chemother
; 61(12)2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28971875
11.
Simeprevir and daclatasvir for 12 or 24 weeks in treatment-naïve patients with hepatitis C virus genotype 1b and advanced liver disease.
Liver Int
; 37(9): 1304-1313, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28135777
12.
Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection.
BMC Gastroenterol
; 17(1): 26, 2017 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28187751
13.
Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study.
BMC Infect Dis
; 17(1): 389, 2017 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28577353
14.
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.
BMC Infect Dis
; 17(1): 420, 2017 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28610605
15.
Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12weeks.
J Hepatol
; 64(2): 301-307, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26476290
16.
Liver Fibrosis Evaluation Using Real-time Shear Wave Elastography in Hepatitis C-Monoinfected and Human Immunodeficiency Virus/Hepatitis C-Coinfected Patients.
J Ultrasound Med
; 35(6): 1299-308, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27151906
17.
Efficacy and safety of simeprevir with PegIFN/ribavirin in naïve or experienced patients infected with chronic HCV genotype 4.
J Hepatol
; 62(5): 1047-55, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25596313
18.
Sustained off-treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue-induced HBeAg seroconversion.
J Viral Hepat
; 26(6): 766-769, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30801868
19.
Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir.
Infect Dis Ther
; 10(4): 2203-2222, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125405
20.
Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping.
Clin Gastroenterol Hepatol
; 7(4): 432-7, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19264574